bioRxiv · 10.1101/2024.06.29.601341
GeneLLM: A Large cfRNA Language Model for Cancer Screening from Raw Reads
Abstract
We present GeneLLM, a novel large language model that offers a transformative approach to non-invasive cancer detection and biomarker discovery by directly interpreting plasma cell-free RNA (cfRNA) sequences. Unlike traditional annotation-dependent methods, GeneLLM operates without prior knowledge, achieving significantly improved multi-cancer detection accuracy. Critically, GeneLLM identifies novel cfRNAs ( pseudo-biomarkers) originating from previously unannotated genomic regions-overlooked by existing methods-offering new therapeutic targets and insights into intercellular communication. This innovative, cost-effective approach bypasses traditional bioinformatics tools, generating novel pseudo-biomarkers that outperform existing methods even with low-depth sequencing data. Consequently, GeneLLM opens new avenues for biomarker discovery and expands our understanding of the extracellular transcriptomes role in cancer development.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Deng, S., Sha, L., Jin, Y., Zhou, T., Wang, C., Liu, Q., Guo, H., Xiong, C., Xue, Y., Li, X., Li, Y., Gao, Y., Hong, M., Xu, J., Chen, S., Wang, P.. 2024-07-02. GeneLLM: A Large cfRNA Language Model for Cancer Screening from Raw Reads. https://doi.org/10.1101/2024.06.29.601341
Cite the original work for its findings. Save a collection to share your selection of sources.